Literature DB >> 23007437

Ligand- and structure-based pregnane X receptor models.

Sandhya Kortagere1, Matthew D Krasowski, Sean Ekins.   

Abstract

The human pregnane X receptor (PXR) is a ligand dependent transcription factor that can be activated by structurally diverse agonists including steroid hormones, bile acids, herbal drugs, and prescription medications. PXR regulates the transcription of several genes involved in xenobiotic detoxification and apoptosis. Activation of PXR has the potential to initiate adverse effects by altering drug pharmacokinetics or perturbing physiological processes. Hence, more reliable prediction of PXR activators would be valuable for pharmaceutical drug discovery to avoid potential toxic effects. Ligand- and protein structure-based computational models for PXR activation have been developed in several studies. There has been limited success with structure-based modeling approaches to predict human PXR activators, which can be attributed to the large and promiscuous site of this protein. Slightly better success has been achieved with ligand-based modeling methods including quantitative structure-activity relationship (QSAR) analysis, pharmacophore modeling and machine learning that use appropriate descriptors to account for the diversity of the ligand classes that bind to PXR. These combined computational approaches using molecular shape information may assist scientists to more confidently identify PXR activators. This chapter reviews the various ligand and structure based methods undertaken to date and their results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007437     DOI: 10.1007/978-1-62703-050-2_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

Review 2.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

Review 3.  Targeting xenobiotic receptors PXR and CAR in human diseases.

Authors:  Monimoy Banerjee; Delira Robbins; Taosheng Chen
Journal:  Drug Discov Today       Date:  2014-11-20       Impact factor: 7.851

4.  Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction.

Authors:  Joshi M Ramanjulu; Shawn P Williams; Ami S Lakdawala; Michael P DeMartino; Yunfeng Lan; Robert W Marquis
Journal:  ACS Med Chem Lett       Date:  2021-08-10       Impact factor: 4.632

5.  SPA70 is a potent antagonist of human pregnane X receptor.

Authors:  Wenwei Lin; Yue-Ming Wang; Sergio C Chai; Lili Lv; Jie Zheng; Jing Wu; Qijun Zhang; Yong-Dong Wang; Patrick R Griffin; Taosheng Chen
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.